Whey Protein This high-cysteine protein isnt just for gym enthusiasts
New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year: New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year: 25% in a year might be a little fast
10.1371/journal.pone.0096411 37
The aims of the present study were to assess GLP-1R expression in primary and metastatic sites of PDAC by immunohistochemical analysis and to examine whether GLP-1R knockdown affected pancreatic cancer cell function
They belong to a class of medications that work by mimicking the bodys natural hormone response to food intake
Intravenous Immunoglobulin (IVIG) Intravenous Immunoglobulin, or IVIG, is a specialized treatment made from antibodies collected from thousands of healthy blood donors
